Literature DB >> 24440524

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.

C Carpentier1, D Ghanem1, F J Fernandez-Gomez1, F Jumeau1, J V Philippe2, F Freyermuth3, A Labudeck1, S Eddarkaoui1, C M Dhaenens1, I Holt4, I Behm-Ansmant2, N Marmier-Gourrier2, C Branlant2, N Charlet-Berguerand3, J Marie5, S Schraen-Maschke1, L Buée1, N Sergeant6, M L Caillet-Boudin7.   

Abstract

The splicing of the microtubule-associated protein Tau is regulated during development and is found to be deregulated in a growing number of pathological conditions such as myotonic dystrophy type I (DM1), in which a reduced number of isoforms is expressed in the adult brain. DM1 is caused by a dynamic and unstable CTG repeat expansion in the DMPK gene, resulting in an RNA bearing long CUG repeats (n>50) that accumulates in nuclear foci and sequesters CUG-binding splicing factors of the muscle blind-like (MBNL) family, involved in the splicing of Tau pre-mRNA among others. However, the precise mechanism leading to Tau mis-splicing and the role of MBNL splicing factors in this process are poorly understood. We therefore used new Tau minigenes that we developed for this purpose to determine how MBNL1 and MBNL2 interact to regulate Tau exon 2 splicing. We demonstrate that an intronic region 250 nucleotides downstream of Tau exon 2 contains cis-regulatory splicing enhancers that are sensitive to MBNL and that bind directly to MBNL1. Both MBNL1 and MBNL2 act as enhancers of Tau exon 2 inclusion. Intriguingly, the interaction of MBNL1 and MBNL2 is required to fully reverse the mis-splicing of Tau exon 2 induced by the trans-dominant effect of long CUG repeats, similar to the DM1 condition. In conclusion, both MBNL1 and MBNL2 are involved in the regulation of Tau exon 2 splicing and the mis-splicing of Tau in DM1 is due to the combined inactivation of both.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Microtubule-associated protein Tau; Muscleblind-like protein; Myotonic dystrophy; Splicing; Tauopathies

Mesh:

Substances:

Year:  2014        PMID: 24440524     DOI: 10.1016/j.bbadis.2014.01.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Mechanistic determinants of MBNL activity.

Authors:  Łukasz J Sznajder; Michał Michalak; Katarzyna Taylor; Piotr Cywoniuk; Michał Kabza; Agnieszka Wojtkowiak-Szlachcic; Magdalena Matłoka; Patryk Konieczny; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2016-10-12       Impact factor: 16.971

2.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

3.  Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts.

Authors:  R Rodríguez; O Hernández-Hernández; J J Magaña; R González-Ramírez; E S García-López; B Cisneros
Journal:  Mol Biol Rep       Date:  2014-10-12       Impact factor: 2.316

Review 4.  RNA-protein interactions in unstable microsatellite diseases.

Authors:  Apoorva Mohan; Marianne Goodwin; Maurice S Swanson
Journal:  Brain Res       Date:  2014-04-04       Impact factor: 3.252

5.  Community structure analysis of transcriptional networks reveals distinct molecular pathways for early- and late-onset temporal lobe epilepsy with childhood febrile seizures.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Priscila Iamashita; Filipi Nascimento Silva; Luciano da Fontoura Costa; Alexandre Valotta Silva; Luiz Henrique Martins Castro; Hung-Tzu Wen
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.

Authors:  Teresa Sposito; Elisavet Preza; Colin J Mahoney; Núria Setó-Salvia; Natalie S Ryan; Huw R Morris; Charles Arber; Michael J Devine; Henry Houlden; Thomas T Warner; Trevor J Bushell; Michele Zagnoni; Tilo Kunath; Frederick J Livesey; Nick C Fox; Martin N Rossor; John Hardy; Selina Wray
Journal:  Hum Mol Genet       Date:  2015-07-01       Impact factor: 6.150

Review 7.  MBNL proteins and their target RNAs, interaction and splicing regulation.

Authors:  Patryk Konieczny; Ewa Stepniak-Konieczna; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2014-09-02       Impact factor: 16.971

Review 8.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

9.  RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Authors:  Roscoe Klinck; Angélique Fourrier; Philippe Thibault; Johanne Toutant; Mathieu Durand; Elvy Lapointe; Marie-Laure Caillet-Boudin; Nicolas Sergeant; Geneviève Gourdon; Giovanni Meola; Denis Furling; Jack Puymirat; Benoit Chabot
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

10.  Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion.

Authors:  Yu-Hsin Lee; Yu-Lin Jhuang; Yu-Ling Chen; Yung-Ming Jeng; Ray-Hwang Yuan
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.